Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Subthreshold Doses of Specific Phosphodiesterase Type 3 and 4 Inhibitors Enhance the Pulmonary Vasodilatory Response to Nebulized Prostacyclin with Improvement in Gas Exchange
Ralph Theo Schermuly, Axel Roehl, Norbert Weissmann, Hossein Ardeschir Ghofrani, Christian Schudt, Herrmann Tenor, Friedrich Grimminger, Werner Seeger and Dieter Walmrath
Journal of Pharmacology and Experimental Therapeutics February 2000, 292 (2) 512-520;
Ralph Theo Schermuly
Axel Roehl
Norbert Weissmann
Hossein Ardeschir Ghofrani
Christian Schudt
Herrmann Tenor
Friedrich Grimminger
Werner Seeger

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 292, Issue 2
1 Feb 2000
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Subthreshold Doses of Specific Phosphodiesterase Type 3 and 4 Inhibitors Enhance the Pulmonary Vasodilatory Response to Nebulized Prostacyclin with Improvement in Gas Exchange
Ralph Theo Schermuly, Axel Roehl, Norbert Weissmann, Hossein Ardeschir Ghofrani, Christian Schudt, Herrmann Tenor, Friedrich Grimminger, Werner Seeger and Dieter Walmrath
Journal of Pharmacology and Experimental Therapeutics February 1, 2000, 292 (2) 512-520;
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Subthreshold Doses of Specific Phosphodiesterase Type 3 and 4 Inhibitors Enhance the Pulmonary Vasodilatory Response to Nebulized Prostacyclin with Improvement in Gas Exchange
Ralph Theo Schermuly, Axel Roehl, Norbert Weissmann, Hossein Ardeschir Ghofrani, Christian Schudt, Herrmann Tenor, Friedrich Grimminger, Werner Seeger and Dieter Walmrath
Journal of Pharmacology and Experimental Therapeutics February 1, 2000, 292 (2) 512-520;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement